Fig. 4.
Fig. 4. PGE2 increases CREB Ser133 phosphorylation, which is involved in STAT5 transactivation. / (A) Western blot analysis of nuclear protein extracts of AS-E2 cells that were pretreated with or without PGE2 (1 μM) and stimulated with or without EPO (2 U/mL) for the indicated periods, using antibodies against Ser133-phosphorylated (αP-S-CREB) and total CREB (αCREB). Shown is a representative blot of 3 independent experiments. (B) STAT5 transactivation assay of AS-E2 cells that had been cotransfected with control vector (pcDNA3) or expressing vector for wild-type or Ser133Ala CREB. Cells were starved for 16 hours, pretreated with or without PGE2 (1 μM), and stimulated with or without EPO (2 U/mL) for 7 hours. Luciferase activities were corrected for β-galactosidase activities and expressed as percentage transactivation of EPO-stimulated control cells without PGE2 pretreatment. The mean values of 3 independent experiments are presented, and SEM values are indicated by bars.

PGE2 increases CREB Ser133 phosphorylation, which is involved in STAT5 transactivation.

(A) Western blot analysis of nuclear protein extracts of AS-E2 cells that were pretreated with or without PGE2 (1 μM) and stimulated with or without EPO (2 U/mL) for the indicated periods, using antibodies against Ser133-phosphorylated (αP-S-CREB) and total CREB (αCREB). Shown is a representative blot of 3 independent experiments. (B) STAT5 transactivation assay of AS-E2 cells that had been cotransfected with control vector (pcDNA3) or expressing vector for wild-type or Ser133Ala CREB. Cells were starved for 16 hours, pretreated with or without PGE2 (1 μM), and stimulated with or without EPO (2 U/mL) for 7 hours. Luciferase activities were corrected for β-galactosidase activities and expressed as percentage transactivation of EPO-stimulated control cells without PGE2 pretreatment. The mean values of 3 independent experiments are presented, and SEM values are indicated by bars.

Close Modal

or Create an Account

Close Modal
Close Modal